• Follow
  • Follow
  • Menu Item

Log in

Start free trial
  • Reports
    • Diagnostic Testing & Emerging Technologies
    • Lab Compliance Advisor
    • Laboratory Industry Report
    • National Lab Reporter
  • Articles
    • Diagnostic Testing and Emerging Technologies
      • DTC-dtet
      • Earnings-dtet
      • Emerging Tests-dtet
      • FDA-dtet
      • G2 Insider-dtet
    • Lab Compliance Advisor
      • Accreditation-lca
      • Brief Your CEO-lca
      • CLIA-lca
      • CMS-lca
      • Coding-lca
      • Compliance Corner-lca
      • Compliance Guidance-lca
      • Compliance Officers-lca
      • Compliance Perspectives-lca
      • Compliance Plans-lca
      • Compliance-lca
      • DOJ-lca
      • Employment-lca
      • Enforcement-lca
      • False Claims-lca
      • FDA-lca
    • Laboratory Industry Report
      • Capital-lir
      • CMS-lir
      • Deals-lir
      • Dx Pipeline-lir
      • Earnings-lir
      • Enforcement-lir
      • FDA-lir
      • Fee Schedules-lir
      • Funding-lir
    • National Lab Reporter
      • Guidelines at a Glance-nir
      • Health care reform-nir
      • HIPAA-nir
      • Labs in Court-nir
      • Legislation-nir
      • News-nir
      • OIG-nir
      • Reimbursement-nir
      • Safety-nir
  • News
  • Industry Perspectives
  • Webinars
  • Store

Diagnostic Testing and Emerging Technologies

LAB COMPLIANCE ADVISOR

LABORATORY INDUSTRY REPORT

NATIONAL LAB REPORTER

The Top 10 Diagnostics Deals of 2021

The Top 10 Diagnostics Deals of 2021

by Glenn S. Demby | Dec 3, 2021 | Articles, Deals-lir, Laboratory Industry Report, Must read

...

This content is for Paid Members only.
Login Register
PerkinElmer Acquires BioLegend While FTC Warns Against Non-Approved Mergers

PerkinElmer Acquires BioLegend While FTC Warns Against Non-Approved Mergers

by Glenn S. Demby | Nov 4, 2021 | Articles, Deals-lir, Laboratory Industry Report

...

This content is for Paid Members only.
Login Register
PerkinElmer Acquires BioLegend While FTC Warns Against Non-Approved Mergers

PerkinElmer Acquires BioLegend While FTC Warns Against Non-Approved Mergers

by Glenn S. Demby | Oct 5, 2021 | Articles, Deals-lir, Laboratory Industry Report

...

This content is for Paid Members only.
Login Register
Illumina Makes Audacious Move by Completing Grail Acquisition Without Regulatory Approval

Illumina Makes Audacious Move by Completing Grail Acquisition Without Regulatory Approval

by Glenn S. Demby | Sep 13, 2021 | Articles, Deals-lir, Laboratory Industry Report

...

This content is for Paid Members only.
Login Register
PerkinElmer Acquires BioLegend While FTC Warns Against Non-Approved Mergers

Biden Orders Feds to Target Health Care Consolidation but Deals Continue

by Glenn S. Demby | Aug 16, 2021 | Articles, Deals-lir, Laboratory Industry Report

...

This content is for Paid Members only.
Login Register
« Older Entries

Log In


Join Now | Lost Password?

  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
Copyright © 2023 G2Intelligence.com